PRESS RELEASE published on 04/29/2026 at 13:39, 3 months 13 days ago Informations privilégiées / Autres communiqués Medincell annonce une forte croissance des ventes de UZEDY aux Etats-Unis, une formulation injectable approuvée par la FDA pour la schizophrénie et le trouble bipolaire. De nouvelles avancées pour l'olanzapine LAI sont également en cours FDA Schizophrénie Medincell Teva UZEDY
PRESS RELEASE published on 04/29/2026 at 13:39, 3 months 13 days ago Inside Information / Other news releases Medincell's partner Teva Pharmaceuticals reports UZEDY Q1 2026 net sales of $63M, a 62% increase year-on-year. Olanzapine LAI NDA accepted by FDA. Medincell focuses on long-acting injectable treatments across various therapeutic areas Medincell Teva Pharmaceuticals Olanzapine LAI UZEDY Long-acting Injectable
BRIEF published on 04/20/2026 at 11:18, 3 months 22 days ago BNP Paribas Développement crosses a threshold at MEDICELL Euronext Paris Voting Rights BNP Paribas Threshold Crossing MEDICELL
BRIEF published on 04/20/2026 at 11:18, 3 months 22 days ago Franchissement de seuil par BNP Paribas Développement chez MEDINCELL Euronext Paris Droits De Vote Franchissement De Seuil BNP Paribas Medincell
PRESS RELEASE published on 04/20/2026 at 11:13, 3 months 22 days ago Franchissement de seuil Déclaration de franchissement de seuil par BNP Paribas Développement concernant MEDINCELL sur Euronext Paris Euronext Paris Droits De Vote Franchissement De Seuil Medincell BNP Paribas Développement
BRIEF published on 04/02/2026 at 19:05, 4 months 10 days ago Medincell : Mise à jour sur le capital et les droits de vote Droits De Vote Euronext Capital Social Actions AMF
BRIEF published on 04/02/2026 at 19:05, 4 months 10 days ago Medincell: Update on capital and voting rights Share Capital Voting Rights Shares Euronext AMF
PRESS RELEASE published on 04/02/2026 at 19:00, 4 months 10 days ago Informations privilégiées / Autres communiqués Euronext MEDCL divulgue les chiffres du capital social et des droits de vote conformément au règlement de l'AMF. Medincell développe des traitements biopharmaceutiques innovants à action prolongée Droits De Vote Euronext Capital Social Medincell MEDCL
BRIEF published on 02/20/2026 at 21:42, 5 months 19 days ago Teva's Olanzapine Injectable Suspension Gains FDA Nod Schizophrenia Olanzapine Teva Pharmaceuticals FDA Acceptance Long-acting Injectable
BRIEF published on 02/20/2026 at 21:42, 5 months 19 days ago La suspension injectable d'olanzapine de Teva obtient l'approbation de la FDA Schizophrénie Olanzapine Teva Pharmaceuticals Acceptation Par La FDA Injectable À Action Prolongée
Published on 08/12/2026 at 15:42, 3 hours 50 minutes ago Critical Elements 10,000-Meter Summer Drill Program at Rose West Resumes with Positive Results
Published on 08/12/2026 at 15:42, 3 hours 50 minutes ago Critical Elements redémarre son programme de forage estival de 10 000 mètres à Rose Ouest avec des résultats positifs
Published on 08/12/2026 at 15:00, 4 hours 32 minutes ago Karbon-X and Core Energy Sign Letter of Intent to Explore Commercial EV Charging Infrastructure in South America
Published on 08/12/2026 at 14:45, 4 hours 47 minutes ago Lobe Sciences Ltd. Announces Non-Brokered Private Placement
Published on 08/12/2026 at 18:17, 1 hour 15 minutes ago EQS-Adhoc: Gateway Real Estate AG resolves segment change from the regulated market (Prime Standard) to the Scale segment of the open market (Freiverkehr) on the Frankfurt Stock Exchange
Published on 08/12/2026 at 18:15, 1 hour 17 minutes ago Shelly Group Delivers Strong Revenue and Earnings Growth in the First Six Months of 2026
Published on 08/11/2026 at 17:45, 1 day 1 hour ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 1 day 1 hour ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 2 days 1 hour ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 days 1 hour ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
